But also: https://www.fiercepharma.com/manufacturing/pfizer-biontech-near-euro-supply-deal-for-up-to-300m-doses-covid-19-vaccine https://www.fiercepharma.com/m

But also: https://www.fiercepharma.com/manufacturing/pfizer-biontech-near-euro-supply-deal-for-up-to-300m-doses-covid-19-vaccine https://www.fiercepharma.com/manufacturing/pfizer-biontech-n... "Analysts specifically cast doubt on Pfizer and BioNTech's rollout plans given the stringent cold-storage needs for their candidate, which must be kept at a frigid -94° Fahrenheit (-70° Celsius), and will last for only 24 hours at refrigerated temps between 35.6°F and 46.4°F (2°-8°C). By contrast, most protein subunit vaccines—the type being developed for COVID-19 by Sanofi and Novavax, among others—can be held at refrigerated temps for months, analysts said."